š—”š—²š˜„š˜€ š—¦š˜‚š—ŗš—ŗš—®š—æš˜†
• Lupin has received tentative approval from the USFDA for its two drugs, Canagliflozin and Metformin Hydrochloride Extended-Release Tablets.
• The products will be manufactured at Lupin's Pithampur facility in India.
• The company's board of directors will hold a meeting on November 8 to approve its unaudited financial results for the quarter and half-year ended September 30, 2023.